Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionOgorek Anthony Joseph /ny/ /adv
Latest Disclosed Ownership98 shares
Latest Disclosed Value $ 7
Ogorek Anthony Joseph /ny/ /adv ownership in EW / Edwards Lifesciences Corporation

On May 12, 2026 - Ogorek Anthony Joseph /ny/ /adv filed a 13F-HR/A form disclosing ownership of 98 shares of Edwards Lifesciences Corporation (MX:EW) valued at $7 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 98 shares of Edwards Lifesciences Corporation.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F/A-1 EW Edward Lifesciences 28176E108 98 0 0.00 0 0.0019
2026-05-11 2026-03-31 13F EW Edward Lifesciences 28176E108 115 17 0 0.0023
2026-01-23 2025-12-31 13F EW Edward Lifesciences 28176E108 98 -17 -14.78 0 0.0022
2025-11-04 2025-09-30 13F EW Edward Lifesciences 28176E108 115 3 2.68 0 0.0023
2025-08-08 2025-06-30 13F EW Edward Lifesciences 28176E108 112 19 20.43 0 0.0025
2025-05-09 2025-03-31 13F EW Edward Lifesciences 28176E108 93 93 0 0.0020
2024-02-09 2023-12-31 13F EW Edward Lifesciences 28176E108 0 -165 -100.00 0 0.0000
2023-10-19 2023-09-30 13F EW Edward Lifesciences 28176E108 165 0 0.00 0 0.0043
2023-08-03 2023-06-30 13F EW Edward Lifesciences 28176E108 165 -314 -65.55 0 0.0057
2023-05-03 2023-03-31 13F EW Edward Lifesciences 28176E108 479 -1,305 -73.15 0 0.0159
2023-01-30 2022-12-31 13F EW Edward Lifesciences 28176E108 1,784 0 0.00 0 -100.00 0.0578
2022-10-20 2022-09-30 13F EW Edward Lifesciences 28176E108 1,784 0 0.00 147 -13.02 0.0698
2022-07-21 2022-06-30 13F EW Edward Lifesciences 28176E108 1,784 0 0.00 169 -19.52 0.0777
2022-04-26 2022-03-31 13F EW Edward Lifesciences 28176E108 1,784 0 0.00 210 -9.09 0.0861
2022-01-18 2021-12-31 13F EW Edward Lifesciences 28176E108 1,784 0 0.00 231 14.93 0.0987
2021-10-27 2021-09-30 13F EW Edward Lifesciences 28176E108 1,784 314 21.36 201 32.24 0.0917
2021-07-14 2021-06-30 13F EW Edward Lifesciences 28176E108 1,470 0 0.00 152 24.59 0.0681
2021-04-26 2021-03-31 13F EW Edward Lifesciences 28176E108 1,470 0 0.00 122 -9.63 0.0601
2021-01-20 2020-12-31 13F EW Edward Lifesciences 28176E108 1,470 0 0.00 135 15.38 0.0723
2020-11-02 2020-09-30 13F EW Edward Lifesciences 28176E108 1,470 0 0.00 117 14.71 0.0690
2020-08-07 2020-06-30 13F EW Edward Lifesciences 28176E108 1,470 890 153.45 102 -6.42 0.0722
2020-04-10 2020-03-31 13F EW Edward Lifesciences 28176E108 580 330 132.00 109 87.93 0.0592
2020-01-21 2019-12-31 13F EW Edward Lifesciences 28176E108 250 0 0.00 58 7.41 0.0283
2019-10-17 2019-09-30 13F EW Edward Lifesciences 28176E108 250 0 0.00 54 17.39 0.0323
2019-07-15 2019-06-30 13F EW Edward Lifesciences 28176E108 250 160 177.78 46 170.59 0.0310
2019-04-08 2019-03-31 13F EW Edward Lifesciences 28176E108 90 0 0.00 17 30.77 0.0113
2019-01-08 2018-12-31 13F EW Edward Lifesciences 28176E108 90 0 0.00 13 -13.33 0.0103
2018-10-17 2018-09-30 13F EW Edward Lifesciences 28176E108 90 90 15 0.0111
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.